tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
admiralonco vs DoseFinding
A side-by-side editorial comparison of admiralonco and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
Shared themes:clinical-trials
admiralonco vs DoseFinding: at a glance
What is admiralonco?
The oncology ADaM helper is dissolving into admiral core, one deprecation at a time.
admiralonco is the oncology companion to admiral, and it ships response-criteria recipes rather than code: RECIST, iRECIST, IMWG, GCIG and PCWG3 each arrive as a vignette plus an ADaM template. Cadence is one or two releases a year, each adding a criteria vignette. The 1.4.0 release began deprecating most of the package's own exported functions in favour of generic admiral equivalents.
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
admiralonco vs DoseFinding: editorial side-by-side
admiralonco
0.0ANALYTICS
The oncology ADaM helper is dissolving into admiral core, one deprecation at a time.
◆ Current state
admiralonco is the oncology companion to admiral, and it ships response-criteria recipes rather than code: RECIST, iRECIST, IMWG, GCIG and PCWG3 each arrive as a vignette plus an ADaM template. Cadence is one or two releases a year, each adding a criteria vignette. The 1.4.0 release began deprecating most of the package's own exported functions in favour of generic admiral equivalents.
◆ Where it's heading
The package is converging on a documentation-and-templates model: reusable derivation logic moves upstream into admiral, and admiralonco keeps only the oncology-specific know-how. Every release since 1.0.0 has added a criteria vignette rather than new exported functions, and 1.4.1 extends that by making the template set browsable from the Get Started menu. The surface users program against is shrinking while the guidance they read is growing.
◆ Prediction
Expect the deprecation cycle started in 1.4.0 to advance through its warning and error phases across the next one or two releases, with new work arriving as another response-criteria vignette rather than new functions.
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Alternatives to admiralonco and DoseFinding
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either admiralonco or DoseFinding.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all admiralonco alternatives → · See all DoseFinding alternatives →
Recent activity from admiralonco and DoseFinding
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 2mo agoadmiraloncoTemplate explorer vignette added to Get Started
- 6mo agoadmiraloncoPSA endpoints land as function deprecation begins ⚡
- 11mo agoadmiraloncoPCWG3 response criteria vignette added
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoadmiraloncoGCIG response criteria vignette added
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoadmiraloncoIMWG response criteria vignette added
- 2y agoadmiraloncoiRECIST response criteria vignette added
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between admiralonco and DoseFinding?
Both compete on the same themes — clinical-trials — within Analytics. admiralonco and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is admiralonco better than DoseFinding?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. admiralonco and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to admiralonco?
Top admiralonco alternatives in Analytics are ranked by recent ship velocity. Browse the "admiralonco alternatives" section above for the current picks, or visit /alternatives/admiralonco for the full list with editorial commentary on each.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.